Cargando…
Boosting therapeutic potency of antibodies by taming Fc domain functions
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious diseases or cancer therapeutics because they selectively target pathogens, infectious cells, cancerous cells, and even immune cells. In this way, they mediate the elimination of target molecules and cells with...
Autores principales: | Kang, Tae Hyun, Jung, Sang Taek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859160/ https://www.ncbi.nlm.nih.gov/pubmed/31735912 http://dx.doi.org/10.1038/s12276-019-0345-9 |
Ejemplares similares
-
Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against Cancer
por: Kang, Tae Hyun, et al.
Publicado: (2020) -
Rational engineering of Fc/Fc receptor interactions to improve antibody potency
por: Doberstein, S, et al.
Publicado: (2003) -
Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering
por: Ko, Sanghwan, et al.
Publicado: (2021) -
Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic
por: Kim, Jin, et al.
Publicado: (2021) -
Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014)